Mineralys Therapeutics, Inc. (MLYS) Net income 2022–2025
Mineralys Therapeutics, Inc. (MLYS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$154.7MFY2025 · since FY2022: -$29.8M → -$154.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$154.7M | +13.0% |
| FY2024 | -$177.8M | -147.3% |
| FY2023 | -$71.9M | -141.3% |
| FY2022 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice